A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease. Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at…
Medical staff shows on February 26, 2020 packets of a Nivaquine, tablets containing chloroquine and Plaqueril, tablets containing hydroxychloroquine, drugs that has shown signs of effectiveness against coronavirus.Gerard Julien | AFP | Getty ImagesHydroxychloroquine, a decades-old malaria drug touted by President Donald Trump, didn't appear to help hospitalized patients with Covid-19, according to a new…
Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : 939bbae3-571a-4358-a806-272dd299
You don't have permission to access "http://www.medpagetoday.com/neurology/alzheimersdisease/117920" on this server. Reference #18.2c153b17.1760385711.296fe6e https://errors.edgesuite.net/18.2c153b17.1760385711.296fe6e
3 min read Vuori’s sale section has been restocked with fall workout clothes. Save up to 50% on editor-approved shorts, T-shirts, hoodies, joggers, and more. The sale also features savings on workout gear, hats, and fall-centric favorites. AT MEN'S HEALTH , we test activewear for a living—and few brands impress us as consistently as Vuori.